-
H3K18 Lactylation in Post-ICH White Matter Injury
2026-09-21
This mouse study identifies microglial H3K18 lactylation as a potentially protective response after intracerebral hemorrhage, linking lactate metabolism and p300/CBP-dependent chromatin regulation to white matter repair. Its inhibitor experiments also show that reducing lactate production and blocking the lactylation writer do not produce identical outcomes, an important consideration for mechanism-focused experimental design.
-
R2 Retrotransposon Insertions and DNA Repair Pathways
2026-09-20
McIntyre, Horton, and Collins identify distinct host DNA-repair routes that stabilize either intact or truncated insertions initiated by an R2 retrotransposon protein. Their PRINT-based study connects target-primed reverse transcription to post-synthesis junction formation and second-strand repair, clarifying how non-LTR retrotransposons can generate stable genomic insertions.
-
Phagocytic Giant Cancer Macrophages in Blood
2026-09-19
A 2025 Cancer Letters study reframes circulating phagocytic polyploid giant cancer macrophages, or CAMLs, as clinically informative and biologically active cells rather than cellular debris. In a prospective, multi-institutional cohort, CAMLs correlated with disease progression and displayed self-renewing, proangiogenic, and overlapping myeloid, epithelial, and endothelial features.
-
From Podocyte Pathways to Better Viability Data
2026-09-18
A translational perspective on how AO/PI Staining Solution can strengthen viability measurements in diabetic nephropathy research, using phillygenin pathway evidence to connect molecular mechanism with reproducible fluorescence-based cell counting.
-
Mithramycin A: A Mechanism-to-Assay Guide
2026-09-18
Mithramycin A is an anticancer antibiotic for dissecting G-C-rich transcriptional control, c-myc regulation, and differentiation. This guide connects its established cancer-biology uses with a rigorous assay framework inspired by the miR-24-3p/Sp1/PI3K study, while separating evidence from exploratory applications.
-
GSK 2837808A: A Flux-Resolved LDHA Strategy
2026-09-17
GSK 2837808A provides a selective way to interrogate LDHA-dependent lactate production without treating glycolysis as a single process. This article develops a flux-resolved framework for connecting glucose consumption reduction with the NAT1–ENO1–lactate–PD-L1 axis while separating validated findings from exploratory cancer metabolism research.
-
Lactate Workflows for Metabolic–Immune Research
2026-09-17
Use L-lactate as both a quantitative metabolic readout and a controlled signaling input across glycolysis, hypoxia, mitochondrial stress, and tumor–immune models. This workflow emphasizes compartment-specific sampling, fresh dosing, and mechanistic controls that distinguish lactate production from lactate-driven PD-L1 regulation.
-
MK-4827 (Niraparib) Lab Guide
2026-09-16
A scenario-based guide to using MK-4827 (Niraparib), a potent and selective PARP-1/-2 inhibitor, in cell viability, proliferation, and cytotoxicity workflows. It explains assay design, solvent handling, resistance models, data interpretation, and vendor-selection considerations for SKU A3617.
-
TH287 MTH1 Inhibitor for Radiosensitization
2026-09-16
TH287 turns MTH1 inhibition into a practical radiosensitization strategy for cancer-cell models, with the strongest reported effect when ionizing radiation follows drug exposure by 12 hours. This guide translates the finding into a controlled workflow, assay design, and troubleshooting plan for oxidative stress-induced DNA damage research.
-
10 mM dNTP Mixture: Reliable DNA Synthesis
2026-09-15
A scenario-based guide to using the 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture, SKU K1041, in PCR, qPCR, sequencing, and cell-assay workflows that depend on molecular readouts. It explains formulation, compatibility, storage, interpretation limits, and practical vendor-selection criteria without overstating what a nucleotide mix can do.
-
Z-WEHD-FMK for Caspase-1 Pyroptosis Studies
2026-09-15
Z-WEHD-FMK provides a cell-permeable, irreversible way to test inflammatory caspase involvement in pyroptosis, cancer biology, and infection models. This practical guide connects the HOXC8–caspase-1 findings in NSCLC with assay design, Chlamydia workflows, dosing, controls, and troubleshooting.
-
TMB in ELISA: From Redox Chemistry to Malaria
2026-09-14
TMB connects peroxidase chemistry with sensitive serological readouts. This guide explains how 3,3′,5,5′-Tetramethylbenzidine can support epitope-based Plasmodium vivax surveillance while preserving rigorous controls, cutoff validation, and assay interpretation.
-
NAT1–ENO1–Lactate Signaling in Colorectal Cancer
2026-09-14
A 2026 MedComm study identifies NAT1 as a metabolic–immune regulator that restrains ENO1 activity, lactate production, and TRAF6-dependent PD-L1 stabilization in colorectal cancer. Its integrated database, multi-omics, cellular, patient, and mouse-model evidence provides a mechanistic framework for linking tumor glycolysis with immune-checkpoint response, while also defining important limits for translating LDHA-focused experiments.
-
Bromodomain Inhibitor, (+)-JQ1: Ferroptosis Workflows
2026-09-13
Bromodomain Inhibitor, (+)-JQ1 provides a practical way to connect BET-dependent chromatin regulation with ferroptosis, apoptosis, inflammation, and BRDT biology. This guide converts the latest BRD4–ROS–FSP1 findings into a controlled cell-assay workflow with application-specific controls and troubleshooting strategies.
-
DAF-2 diacetate for Nitric Oxide Imaging
2026-09-12
DAF-2 diacetate combines cell permeability, intracellular retention, and sensitive fluorescence for mapping nitric oxide in live cells and experimental tissues. This practical guide connects probe handling with sulfur-dependent redox biology, including assay designs for endothelial, immune, neuronal, and soybean nodule research.